# Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer

> **NCT00673127** · PHASE2 · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 57 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Ketoconazole, Hydrocortisone and Dutasteride

## Key facts

- **NCT ID:** NCT00673127
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2012-02
- **Final completion:** 2012-12
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2015-04-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00673127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00673127, "Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00673127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*